Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer 02 Aug 2022 Giving people with bladder cancer chemotherapy and radiotherapy at the same time helps stop cancer from coming back, long-term results of a 10-year study confirm. Find out more Show/Hide
'Man Van' launched to speed up early diagnosis of prostate cancer and improve healthcare access 21 Mar 2022 The 'Man Van', an innovative new outreach programme, has been launched today to provide free health checks for men and boost early diagnosis of prostate and other urological cancers. Find out more Show/Hide
Abiraterone could halve risk of prostate cancer death for some patients 23 Dec 2021 Adding abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading*, could halve the risk of death from the disease. Find out more Show/Hide
ICR welcomes NICE’s decision to reassess abiraterone as first-line treatment for advanced prostate cancer 29 Oct 2020
Men in England and Wales miss out on abiraterone as first-line treatment for advanced prostate cancer 26 Jun 2020
Approval of targeted therapies first line for prostate cancer ‘will ease COVID-19 pressures’ 06 May 2020
The ICR responds to approval of abiraterone as first-line treatment for advanced prostate cancer on the NHS in Scotland 13 Jan 2020